Laura R. Parham

Prospective Validation of <i>HLA-DRB1</i>*<i>07:01</i> Allele Carriage As a Predictive Risk Factor for Lapatinib-Induced Liver Injury

Daniel J. Schaid, Colin F. Spraggs, Shannon K. McDonnell et al. · Journal of Clinical Oncology · 2014 · 75 citations

Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01

Laura R. Parham, Linda P. Briley, L Li et al. · The Pharmacogenomics Journal · 2015 · 60 citations · Full text

A Randomized Phase 2 Study of an Anti–Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration

Philip J. Rosenfeld, Brian B. Berger, Elias Reichel et al. · Ophthalmology Retina · 2018 · 54 citations

Ocular Disease, Alzheimer's Disease, Ophthalmology +8

Lapatinib-Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes

Colin F. Spraggs, Laura R. Parham, Christine M. Hunt et al. · Clinical Pharmacology & Therapeutics · 2012 · 50 citations

Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis

Lynn D. Condreay, Laura R. Parham, Xiaoyan A. Qu et al. · Rheumatology International · 2020 · 28 citations · Full text